Clinical trial
DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)
NCT00187187 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00187187 |
|---|---|
| Title | DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) |
| Official title | DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) |
| Acronym | DAVIDII |
| Lead sponsor | Abbott Medical Devices, Industry |
| Collaborators | University of Washington |
| Status | Completed |
| Study type | Interventional |
| Conditions | Ventricular Tachycardia, Ventricular Fibrillation, Sudden Cardiac Death, Congestive Heart Failure |
| Intervention type | Device |
| Interventions | Implantable Defibrillator (ICD) |
| Enrollment | 600 |
| Start date | Jun 1, 2003 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 4, 2019 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: